meta_analysis
    2016
    High Quality

    Effects of silymarin supplementation on glycemic control in patients with type 2 diabetes: a systematic review and meta-analysis

    Voroneanu L, Nistor I, Dumea R

    Published in Journal of Diabetes Research

    Key Findings

    Silymarin reduced fasting glucose and HbA1c versus placebo in type 2 diabetes, though trials were small and mostly from one region.

    Conclusions

    Plausible glycaemic benefit needing replication.

    Limitations

    Small trials, possible publication bias.

    Supplements Studied

    Silymarin reduced fasting glucose and HbA1c versus placebo in type 2 diabetes.

    Outcomes Measured

    Blood Sugar Balance

    Silymarin reduced fasting glucose and HbA1c compared with placebo.

    Related Health Concerns

    Type 2 Diabetes

    Study Details

    Year:2016
    Sample Size:270
    Quality Score:7/10

    Access Study

    View on DOIView on PubMedOriginal Source

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.